about
Ecstasy analogues found in cactiMeasuring substance use in the club setting: a feasibility study using biochemical markers.[Laser-assisted, intraoperative diagnosis of tumor fluorescence with disulfonated aluminum-phthalocyanine as an aid in the microsurgical removal of brain tumors. Animal experiment studies]Direct screening of urine for MDMA and MDA by liquid chromatography-tandem mass spectrometry.Multicomponent screening for drugs of abuse: direct analysis of urine by LC-MS-MS.Application of direct urine LC-MS-MS analysis for screening of novel substances in drug abusers.Precise determination of glucose-d(2)/glucose ratio in human serum and plasma by APCI LC-MS/MS.The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivoMT-45, a new psychoactive substance associated with hearing loss and unconsciousness.Morphine formation from ethylmorphine: implications for drugs-of-abuse testing in urine.Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trialUse of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study.On the accurate measurement of serotonin in whole blood.5-hydroxytryptophol as a marker for recent alcohol intake.Field-adapted sampling of whole blood to determine the levels of amodiaquine and its metabolite in children with uncomplicated malaria treated with amodiaquine plus artesunate combinationTherapeutic drug monitoring for tomorrow.Methods for urine drug testing using one-step dilution and direct injection in combination with LC-MS/MS and LC-HRMS.Use of LC-HRMS in full scan-XIC mode for multi-analyte urine drug testing - a step towards a 'black-box' solution?Comparable lumefantrine oral bioavailability when co-administered with oil-fortified maize porridge or milk in healthy volunteers.Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected Ugandans.A field-adapted sampling and HPLC quantification method for lumefantrine and its desbutyl metabolite in whole blood spotted on filter paper.Application of drug testing using exhaled breath for compliance monitoring of drug addicts in treatment.European Guidelines for Workplace Drug Testing in Oral Fluid.Serotonin and its 5-HT1 receptor in human mastocytosis.Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS.Urine and plasma pharmacokinetics of codeine in healthy volunteers: implications for drugs-of-abuse testing.Acamprosate determinations in plasma and cerebrospinal fluid after multiple dosing measured by liquid chromatography-mass spectroscopy: a pharmacokinetic study in healthy volunteers.Effect of ceftobiprole on the normal human intestinal microflora.Method for determination of methadone in exhaled breath collected from subjects undergoing methadone maintenance treatment.Amphetamines detected in exhaled breath from drug addicts: A new possible method for drugs-of-abuse testing.Comparison of analytical approaches for liquid chromatography/mass spectrometry determination of the alcohol biomarker ethyl glucuronide in urine.Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.Chromatographic screening for zopiclone and metabolites in urine using liquid chromatography and liquid chromatography-mass spectrometry techniques.Comparison of urinary excretion characteristics of ethanol and ethyl glucuronide.Growth hormone replacement therapy induces codeine clearance.Direct quantification of ethyl glucuronide in clinical urine samples by liquid chromatography-mass spectrometry.Exhaled breath for drugs of abuse testing - evaluation in criminal justice settings.Clinical trial of a new technique for drugs of abuse testing: a new possible sampling technique.Use of morphine and 6-monoacetylmorphine in blood for the evaluation of possible risk factors for sudden death in 192 heroin users.
P50
Q28291522-B85E00C1-03EC-4678-BD53-8A7E4B863D5AQ30412845-1E20635A-1500-4761-9908-4D2D12CB3240Q32083687-462DEE12-E825-4307-85C9-BBBFF75DFD71Q33426502-4D8992C3-146D-4C80-BC8E-564EF4ACA8B1Q33430934-8A20B95A-AAD3-4B32-846F-65414FEEAFD3Q33433609-C0C2CE49-E2EB-4F25-937B-6629497704F9Q33444380-376B4AF6-8334-4988-B33A-EF82E18DD3FEQ33577839-BD3D41C2-6387-4EB5-AB59-426C33075C0CQ34436183-42E70E6F-9708-4BEF-99F4-0CADF3BED06BQ34464552-F353F7E6-6494-4C8B-8FBA-501CF2135013Q34481951-A345C312-EB6D-4052-AB2D-AC3C79720959Q34509672-11D9783B-9B49-4C0A-8B3F-215C142CA919Q34755304-F3BE5F8B-72F1-4AA0-BD34-FA171FFE8CD2Q35675688-76324868-C45C-44E7-A93E-A96FC82EFC4BQ37182220-74F6E0E7-21A5-4937-9400-1A06F5BB5ECAQ38103768-C369FD7E-DAA6-4EDC-A571-6EA9C0CDC03AQ38266513-3161B6B7-9288-45B6-AEAD-F284243FEE95Q38792388-E4837C22-DB6E-4E2C-8070-60B9785E4D9FQ38865815-54BCBF5E-B3DD-4DBE-BBF3-5F1821D2539BQ38868951-53AE228A-6A58-40F0-A691-A70BB6F612D6Q38875295-B9AED5B0-589B-41F3-BB65-1B7AB4C67444Q39063769-3570203E-0EBC-4AE0-BA05-CA0126ACCA08Q39402379-52BB77FC-B896-4F86-AF94-FA06EA7D0D71Q39407815-F22D40A8-FF21-48C1-BDB6-E6BB4663DD8FQ42617056-EE00F95D-05C5-4520-A3A4-65DCA5E201C2Q42644765-0BD95EC1-D4DC-469F-AF79-3013BB66E6F0Q42666040-075700F4-DA0D-4B60-B678-658AA95BA140Q42868284-DC56F0A1-B4BB-47D2-8EC5-AD6BD100FBFDQ42967312-BEDAA2E4-7540-4EA5-9FC7-66A16383652CQ43042391-BC7F9626-68D3-4901-91C5-05B3BBE06BBFQ43055119-003324F5-33EB-4BC2-B60A-E03BCCEBA109Q43218428-9981E571-D567-43C7-AF84-9BF653872079Q43977082-3FB7A4B0-9EF1-453C-AB33-9DEC2E03AE79Q44000975-3C29FF00-82AC-4B57-8957-B3B4DD5B03FCQ44020573-D91198C3-91C7-4F97-9ACE-9A88C2887FBCQ44086560-BF93387B-0968-409C-BC5C-0CFB89AB3159Q44157302-E9CB184D-6D85-4363-BB8E-9ED5E735370DQ44227093-3CC5D535-D6DA-4C1B-9D11-BC3007914EB4Q44273842-D1080260-191E-4E18-BAAD-915677E77A59Q44373618-21E86EE0-43DC-464E-8B92-48C68E10208B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Olof Beck
@ast
Olof Beck
@en
Olof Beck
@es
Olof Beck
@nl
Olof Beck
@sl
type
label
Olof Beck
@ast
Olof Beck
@en
Olof Beck
@es
Olof Beck
@nl
Olof Beck
@sl
prefLabel
Olof Beck
@ast
Olof Beck
@en
Olof Beck
@es
Olof Beck
@nl
Olof Beck
@sl
P106
P21
P31
P496
0000-0002-3546-8872